TRUST4RD: tool for reducing uncertainties in the evidence generation for specialised treatments for rare diseases
Many treatments developed for rare diseases will have an Orphan Medicinal Product (OMP) designation, indicating that they are likely to deliver benefit in an area of high unmet need. Their approval may be base...
Orphanet Journal of Rare Diseases 2020 15:127


No hay comentarios:
Publicar un comentario